Brazil Gets Down To Implementing ICH Guidelines
Executive Summary
Brazil’s medicines regulator ANVISA has begun the process of implementing International Council for Harmonisation guidelines on areas such as clinical safety data management and the Common Technical Document.
You may also be interested in...
Brazilian Regulator Wins Place On ICH Management Committee
Brazil’s pharmaceutical industry has welcomed the election of medicines regulator ANVISA to the management committee of the International Council for Harmonization.
Brazil ‘Internationalizes’ GMP Regulatory Framework
Brazilian medicines regulator Anvisa has approved a new regulatory framework for good manufacturing practices, bringing it into line with PIC/S standards.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.